References
- Kbom KA. Restless Legs Syndrome. Acta Medica Scandinavica 1945; 158(Suppl): 122.
- Bayard M, Bailey B, Acharya D, Ambreen F, Duggal S, Kaur T, et al. Bupropion and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med 2011; 24(4): 422–8. [CrossRef]
- Sethi KD, Mehta SH. A clinical primer on restless legs syndrome: what we know, and what we don't know. Am J Manag Care 2012; 18(Suppl5): S83–S8.
- Salas RE, Kwan AB. The real burden of restless legs syndrome: clinical and economic outcomes. Am J Manag Care 2012; 18(Suppl9): S207–S12.
- Aurora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 2012; 35(8): 1039–62.
- Nagandla K, De S. Restless legs syndrome: pathophysiology and modern management. Postgrad Med J 2013; 89(1053): 402–10. [CrossRef]
- Karroum E, Konofal E, Arnulf I. Restless-legs syndrome. Rev Neurol (Paris). 2008; 164(8–9): 701–21. [CrossRef]
- Miyamoto M, Miyamoto T, Iwanami M, Suzuki K, Hirata K. Pathophysiology of restless legs syndrome. Brain Nerve 2009; 61(5): 523–32.
- Park YM, Lee HJ, Kang SG, Cho JH, Kim L. Resolution of pregabalin and mirtazapine associated restless legs syndrome by bupropion in a patient with major depressive disorder. Psychiatry Investig 2009; 6(4): 313–5. [CrossRef]
- Buchfuhrer MJ. Contemporary challenges and strategies for improving outcomes for patients with restless legs syndrome. Am J Manag Care 2012; 18(Suppl12): S283–S90.
- Sevim S, Dogu O, Kalaegasi H, Aral M, Metin O, Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless leg syndrome: A population based survey. J Neurol Neurosurg Psychiatry 2004; 75(2): 226–30.
- Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005; 28(7): 891–8.
- Ravi Gupta, Vivekananda Lahan, and Deepak Goel. Prevalence of restless leg syndrome in subjects with depressive disorder. Indian J Psychiatry 2013; 55(1): 70–3. [CrossRef]
- Rottach KG, Schaner BM, Kirch MH, Zivotofsky AZ, Teufel LM, Gallwitz T, et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 2008; 43(1): 70–5. [CrossRef]
- Lee JJ, Erdos J, Wilkosz MF, LaPlante R, Wagoner B. Bupropion as a possible treatment option for restless legs syndrome. Ann Pharmacother 2009; 43(2): 370–4.
- Deniz T, Orhan FO, Karaaslan MF, The Levels of Depression and Somatization in Restless Legs Syndrome. Klinik Psikofarmakoloji Bulteni- Bulletin of Clinical Psychopharmacology 2009; 19(2): 143–7.
- Buturak SV, Yazici K, Yazici AE, Tot S, Basterzi AD. Restless Legs Syndrome in an Elderly Patient Induced by Combined Use of Low Dose Quetiapine and Citalopram. Klinik Psikofarmakoloji Bulteni- Bulletin of Clinical Psychopharmacology 2012; 22(3): 271–4.
- James R. Connor, Xin-Sheng Wang, Richard P. Allen, John L. Beard, Jason A. Wiesinger, Barbara T. Felt, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain 2009:132(Pt 9);2403–12. [CrossRef]
- Dunlop BW, Nemeroff CB. The Role of Dopamine in the Pathophysiology of Depression. Arch Gen Psychiatry 2007; 64(3): 327–37. [CrossRef]
- Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor. Prim Care Companion J Clin Psychiatry 2004; 6(4): 159–66. [CrossRef]